Product Information

PROTONIX 40 MG SUSPENSION is a brand product labeled by Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc., priced at $14.1015 per EA under NDC 00008084402. Its NADAC has been published 657 times since Nov 28, 2013.

The High Outlier badge above means this manufacturer's average price in the PANTOPRAZOLE SODIUM market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

PROTONIX 40 MG SUSPENSION

PANTOPRAZOLE SODIUM
$14.1015per EA
High Outlier

Strength

40 mg/1

NDC

00008084402

Classification

Brand

Dosage Form

GRANULE, DELAYED RELEASE

Route

ORAL

Last Updated

6/17/2026

Active Ingredients

PANTOPRAZOLE SODIUM

Approval Type

New Drug (NDA)

FDA Application

NDA022020

On Market Since

2/29/2008

Pharmacological Classes

Proton Pump Inhibitor
Proton Pump Inhibitors

Price Statistics

The NADAC for PROTONIX 40 MG SUSPENSION has been published 657 times since Nov 28, 2013, and over the history we have for it it has risen 129.5%. The table below summarizes its recorded NADAC range and movement.

Current price$14.1015 per EA
All-time high$16.6963 (Nov 29, 2023)
All-time low$6.1440 (Nov 28, 2013)
52-week high$14.2436
52-week low$13.7995
Median price$13.8581
Average price$13.0416
Largest weekly change-17.0% (Dec 6, 2023)
Weeks tracked657
Tracking sinceNov 28, 2013

Price History

1W

0.0%

1M

-1.0%

3M

-0.9%

6M

+2.1%

1Y

+2.0%

3Y

-15.5%

5Y

-7.8%

All

+129.5%

Generic Alternatives

The matcher finds 6 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 6 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 100% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of PROTONIX 40 MG SUSPENSION?

The current National Average Drug Acquisition Cost (NADAC) for PROTONIX 40 MG SUSPENSION, manufactured by Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc., is $14.1015 per EA (NDC 00008084402), effective Jun 24, 2026.

How has the price of PROTONIX 40 MG SUSPENSION changed over time?

Over the history we have for it, the NADAC for PROTONIX 40 MG SUSPENSION has risen 129.5%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for PROTONIX 40 MG SUSPENSION?

Since Nov 28, 2013, the NADAC for PROTONIX 40 MG SUSPENSION has ranged from a low of $6.1440 (Nov 28, 2013) to a high of $16.6963 (Nov 29, 2023), with a median of $13.8581 per EA.

Are there cheaper alternatives to PROTONIX 40 MG SUSPENSION?

Yes. 6 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, PANTOPRAZOLE SOD DR 40 MG TAB, is $0.0361 per EA — about 100% below PROTONIX 40 MG SUSPENSION.

Who manufactures PROTONIX 40 MG SUSPENSION?

PROTONIX 40 MG SUSPENSION (NDC 00008084402) is labeled by Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc., and CMS classifies it as a brand product.